Aratana Therapeutics, Inc. was a big mover last session, as the company saw its shares rise more than 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, trading within a volatile range of $3.72-$4.43 in the past one-month time frame, showed a sharp increase yesterday.

The stock was driven after the sources say that the company is expected to soar higher on Pet Therapeutic Entyce.

The company has seen a mixed track record when it comes to estimate revisions of one increase and one decrease over the past one month, while the Zacks Consensus Estimate has moved higher in the said time period. The recent price action is also encouraging, so make sure to keep a close watch on this firm in the near future.

Aratana Therapeutics currently has a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%.

A better-ranked stock in the Medical - Drugs industry is BioSpecifics Technologies Corp. , which currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is PETX going up? Or down? Predict to see what others think: Up or Down

Will You Make a Fortune on the Shift to Electric Cars?
 
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>